Climb Bio, Inc. (CLYM)
11.00
+0.71
(+6.90%)
USD |
NASDAQ |
Nov 09, 16:00
11.00
0.00 (0.00%)
After-Hours: 19:58
Climb Bio Total Return Level : 10.29 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 10.29 |
| November 05, 2026 | 8.87 |
| November 04, 2026 | 9.33 |
| November 03, 2026 | 9.75 |
| November 02, 2026 | 9.74 |
| October 30, 2026 | 10.25 |
| October 29, 2026 | 10.33 |
| October 28, 2026 | 10.12 |
| October 27, 2026 | 9.57 |
| October 26, 2026 | 8.81 |
| October 23, 2026 | 10.19 |
| October 22, 2026 | 10.54 |
| October 21, 2026 | 10.87 |
| October 20, 2026 | 10.80 |
| October 19, 2026 | 9.73 |
| October 16, 2026 | 9.82 |
| October 15, 2026 | 10.91 |
| October 14, 2026 | 10.29 |
| October 13, 2026 | 10.31 |
| October 12, 2026 | 10.83 |
| October 09, 2026 | 11.00 |
| October 08, 2026 | 10.86 |
| October 07, 2026 | 10.71 |
| October 06, 2026 | 10.68 |
| October 05, 2026 | 11.05 |
| Date | Value |
|---|---|
| October 02, 2026 | 10.94 |
| October 01, 2026 | 11.07 |
| September 30, 2026 | 11.47 |
| September 29, 2026 | 11.50 |
| September 28, 2026 | 11.74 |
| September 25, 2026 | 11.66 |
| September 24, 2026 | 11.89 |
| September 23, 2026 | 12.52 |
| September 22, 2026 | 14.21 |
| September 21, 2026 | 13.64 |
| September 18, 2026 | 14.05 |
| September 17, 2026 | 14.06 |
| September 16, 2026 | 14.11 |
| September 15, 2026 | 13.91 |
| September 14, 2026 | 14.56 |
| September 11, 2026 | 14.25 |
| September 10, 2026 | 14.95 |
| September 09, 2026 | 15.05 |
| September 08, 2026 | 15.90 |
| September 04, 2026 | 15.52 |
| September 03, 2026 | 14.59 |
| September 02, 2026 | 15.05 |
| September 01, 2026 | 14.82 |
| August 31, 2026 | 13.73 |
| August 28, 2026 | 14.57 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Korsana Biosciences, Inc. | 31.05 |
| Cullinan Therapeutics, Inc. | 11.31 |
| Q32 Bio, Inc. | 9.25 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |